Minerva Neurosciences NERV
NASDAQ NERV
$3.28 +0.05 (+1.55%)
At close: Oct 2, 2026 · 4:00 PM EDT

Minerva Neurosciences (NERV) Interest & Investment Income (2013 - 2026)

Updated

Minerva Neurosciences (NERV) posted Interest & Investment Income of $569,591 for Q2 2026, up 316.8% from $136,671 a year earlier but down 9.5% from the prior quarter.

Analysis

Minerva Neurosciences (NERV) Interest & Investment Income (2013 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Interest & Investment Income at Minerva Neurosciences was $1.85 million, up 118.3% year-over-year; for FY2025, it was $948,122, down 25.5% from FY2024.

  • Annual Interest & Investment Income shows a five-year compound annual growth rate of 42.5% (FY2020 to FY2025).
  • In prior years, Minerva Neurosciences' Interest & Investment Income was $1.27 million in FY2024 (-11.5%), $1.44 million in FY2023 (+158.1%), $556,946 in FY2022 and $16,516 in FY2021 (-89.8%).
  • Quarterly Interest & Investment Income has run from a low of $3,694 in Q4 2021 to a high of $629,602 in Q1 2026 over five years.
  • On a year-over-year basis, Interest & Investment Income has increased in each of the last three quarters, with growth averaging 64.4% over the last eight quarters.
  • The strongest year-over-year quarter for Interest & Investment Income in the past five years was Q2 2023, with growth of 405.2%; the weakest was Q3 2025, with a decline of 66.0%.
  • According to Business Quant data, Interest & Investment Income for the three prior quarters was $629,602 (Q1 2026), $546,523 (Q4 2025) and $106,640 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 219.00 Mn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 80.00 Mn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Minerva Neurosciences 154.91 Mn 154.91 Mn - 569,591.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 569,591.00
Mar 31, 2026 629,602.00
Dec 31, 2025 546,523.00
Sep 30, 2025 106,640.00
Jun 30, 2025 136,671.00
Mar 31, 2025 158,288.00
Dec 31, 2024 239,724.00
Sep 30, 2024 313,967.00
Jun 30, 2024 360,755.00
Mar 31, 2024 357,908.00
Dec 31, 2023 358,883.00
Sep 30, 2023 348,681.00
Jun 30, 2023 365,623.00
Mar 31, 2023 364,218.00
Dec 31, 2022 297,060.00
Sep 30, 2022 180,091.00
Jun 30, 2022 72,378.00
Mar 31, 2022 7,417.00
Dec 31, 2021 3,694.00
Sep 30, 2021 4,156.00
API Access

Minerva Neurosciences Interest & Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=NERV&period=max&api_key=YOUR_API_KEY